Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 12/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | CNR2 | P34972 | 3/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.50 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 2/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10632834 | 0.85 | CDC25A (0.62) | CDC25AALDH1A1MEN1KMT2AHSD17B10 | |
| SCHEMBL2823271 | 0.80 | ALDH1A1 (0.59) | ALDH1A1MEN1KMT2AHSD17B10EGFR | |
| SCHEMBL1129549 | 0.77 | CDC25A (0.80) | CDC25AALDH1A1MEN1KMT2AHSD17B10 | |
| SCHEMBL3026352 | 0.76 | CCKBR (0.45) | ALDH1A1MEN1KMT2AHSD17B10EGFR | |
| SCHEMBL29131197 | 0.76 | CDC25A (0.60) | CDC25AALDH1A1MEN1KMT2AHSD17B10 | |
| SCHEMBL7099245 | 0.76 | EGFR (0.40) | ALDH1A1MEN1KMT2AHSD17B10EGFR | |
| SCHEMBL4595442 | 0.75 | ALDH1A1 (0.75) | CDC25AALDH1A1MEN1KMT2AHSD17B10 | |
| SCHEMBL28227485 | 0.75 | CDC25A (0.62) | CDC25AALDH1A1MEN1KMT2AHSD17B10 | |
| Hydrochloric Acid SCHEMBL7497399 | 0.75 | CDC25A (0.59) | CDC25AALDH1A1MEN1KMT2AHSD17B10 | |
| SCHEMBL14154017 | 0.72 | HDAC4 (0.73) | MEN1KMT2AEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180200225-A1 | HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2018-07-19 | — | — | US | disclosed |
| US-20170231953-A1 | HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS | CLEVELAND CLINIC FOUND (US) | 2017-08-17 | — | — | US | disclosed |
| US-9656957-B2 | Hydrazone modulators of cannabinoid receptors | THE CLEVELAND CLINIC FOUNDATION (US) | 2017-05-23 | — | — | US | disclosed |
| US-20150313874-A1 | HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2015-11-05 | — | — | US | disclosed |
| US-9079854-B2 | Hydrazone modulators of cannabinoid receptors | THE CLEVELAND CLINIC FOUNDATION (US) | 2015-07-14 | — | — | US | disclosed |
| US-20130184275-A1 | HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2013-07-18 | — | — | US | disclosed |
| US-8309595-B2 | Hydrazone modulators of cannabinoid receptors | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-11-13 | — | — | US | disclosed |
| US-20100197755-A1 | HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2010-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170231953-A1 | HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS | CNR1, CNR2, GPR18 | CDC25A 2577/4885ALDH1A1 2096/4885MEN1 4169/4885 |
| US-20150313874-A1 | HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS | CNR1, CNR2, GPR18 | CDC25A 2577/4885ALDH1A1 2096/4885MEN1 4169/4885 |
| US-20100197755-A1 | HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS | CNR1, CNR2, GPR18 | CDC25A 2577/4885ALDH1A1 2096/4885MEN1 4169/4885 |
| US-20130184275-A1 | HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS | CNR1, CNR2, GPR18 | CDC25A 2577/4885ALDH1A1 2096/4885MEN1 4169/4885 |
| US-20180200225-A1 | HYDRAZONE MODULATORS OF CANNABINOID RECEPTORS | CNR1, CNR2, GPR18 | CDC25A 2577/4885ALDH1A1 2096/4885MEN1 4169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.